A 56-year-old man with type 2 diabetes, central obesity, and…
A 56-year-old man with type 2 diabetes, central obesity, and mildly elevated aminotransferases is being evaluated for metabolic dysfunction-associated steatotic liver disease (MASLD). Which factor places him at the highest risk for advanced hepatic fibrosis?
Read Details